Bunker AM - Search Results

1

Rational design, synthesis, and biological activity of benzoxazinones as novel factor Xa inhibitors.

Dudley DA, Bunker AM, Chi L, Cody WL, Holland DR, Ignasiak DP, Janiczek-Dolphin N, McClanahan TB, Mertz TE, Narasimhan LS, Rapundalo ST, Trautschold JA, Van Huis CA, Edmunds JJ. Dudley DA, et al. Among authors: bunker am. J Med Chem. 2000 Nov 2;43(22):4063-70. doi: 10.1021/jm000074l. J Med Chem. 2000. PMID: 11063603

2

Derivatives of 5-[[1-(4'-carboxybenzyl)imidazolyl]methylidene]hydantoins as orally active angiotensin II receptor antagonists.

Edmunds JJ, Klutchko S, Hamby JM, Bunker AM, Connolly CJ, Winters RT, Quin J 3rd, Sircar I, Hodges JC, Panek RL, et al. Edmunds JJ, et al. Among authors: bunker am. J Med Chem. 1995 Sep 15;38(19):3759-71. doi: 10.1021/jm00019a005. J Med Chem. 1995. PMID: 7562906

3

Nonpeptide angiotensin II receptor antagonists. 2. Design, synthesis, and structure-activity relationships of 2-alkyl-4-(1H-pyrrol-1-yl)-1H-imidazole derivatives: profile of 2-propyl-1-[[2'-(1H-tetrazol-5-yl)-[1,1' -biphenyl]-4-yl]-methyl]-4-[2-(trifluoroacetyl)-1H-pyrrol-1-yl]-1H- imidazole-5-carboxylic acid (CI-996).

Sircar I, Hodges JC, Quin J 3rd, Bunker AM, Winters RT, Edmunds JJ, Kostlan CR, Connolly C, Kesten SJ, Hamby JM, et al. Sircar I, et al. Among authors: bunker am. J Med Chem. 1993 Aug 6;36(16):2253-65. doi: 10.1021/jm00068a002. J Med Chem. 1993. PMID: 8360871

4

Endothelin receptor antagonists: synthesis and structure-activity relationships of substituted benzothiazine-1,1-dioxides.

Berryman KA, Edmunds JJ, Bunker AM, Haleen S, Bryant J, Welch KM, Doherty AM. Berryman KA, et al. Among authors: bunker am. Bioorg Med Chem. 1998 Sep;6(9):1447-56. doi: 10.1016/s0968-0896(98)00080-7. Bioorg Med Chem. 1998. PMID: 9801816

5

Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritis.

Li JJ, Nahra J, Johnson AR, Bunker A, O'Brien P, Yue WS, Ortwine DF, Man CF, Baragi V, Kilgore K, Dyer RD, Han HK. Li JJ, et al. J Med Chem. 2008 Feb 28;51(4):835-41. doi: 10.1021/jm701274v. Epub 2008 Feb 6. J Med Chem. 2008. PMID: 18251495

6

N-(6,7-dichloro-2,3-dioxo-1,2,3,4-tetrahydroquinoxalin-5-yl)-N-alkylsulfonamides as peripherally restricted N-methyl-D-aspartate receptor antagonists for the treatment of pain.

Deur C, Agrawal AK, Baum H, Booth J, Bove S, Brieland J, Bunker A, Connolly C, Cornicelli J, Dumin J, Finzel B, Gan X, Guppy S, Kamilar G, Kilgore K, Lee P, Loi CM, Lou Z, Morris M, Philippe L, Przybranowski S, Riley F, Samas B, Sanchez B, Tecle H, Wang Z, Welch K, Wilson M, Yates K. Deur C, et al. Bioorg Med Chem Lett. 2007 Aug 15;17(16):4599-603. doi: 10.1016/j.bmcl.2007.05.083. Epub 2007 May 31. Bioorg Med Chem Lett. 2007. PMID: 17562362

7

Synthesis and structure-activity relationship of imidazo(1,2-a)thieno(3,2-e)pyrazines as IKK-beta inhibitors.

Belema M, Bunker A, Nguyen VN, Beaulieu F, Ouellet C, Qiu Y, Zhang Y, Martel A, Burke JR, McIntyre KW, Pattoli MA, Daloisio C, Gillooly KM, Clarke WJ, Brassil PJ, Zusi FC, Vyas DM. Belema M, et al. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4284-9. doi: 10.1016/j.bmcl.2007.05.031. Epub 2007 May 16. Bioorg Med Chem Lett. 2007. PMID: 17540562

8

Cyclopentanone ring-cleaved pleuromutilin derivatives.

Springer DM, Bunker A, Luh BY, Sorenson ME, Goodrich JT, Bronson JJ, DenBleyker K, Dougherty TJ, Fung-Tomc J. Springer DM, et al. Eur J Med Chem. 2007 Jan;42(1):109-13. doi: 10.1016/j.ejmech.2006.07.018. Epub 2006 Dec 6. Eur J Med Chem. 2007. PMID: 17156897

9

Regular Exercise is Associated with a More Favorable Cardiovascular Risk Profile, Better Quality of Life, Less Depression and Less Psychological Stress.

Schrader B, Bünker AM, Conradi C, Lüders S, Vaske B, Koziolek M, Haller H, Elsässer A, Schrader J. Schrader B, et al. Among authors: bunker am. Int J Gen Med. 2022 Jan 13;15:545-554. doi: 10.2147/IJGM.S338496. eCollection 2022. Int J Gen Med. 2022. PMID: 35058709 Free PMC article.

10

Influence of individualized prevention recommendations after one year on the control of hypertension in 3,868 follow-up participants of the ELITE study.

Schrader B, Schrader J, Koziolek M, Elsässer A, Bünker AM, Hillmann B, Vaske B, Haller H, Lüders S. Schrader B, et al. Among authors: bunker am. Cent Eur J Public Health. 2021 Dec;29(4):305-310. doi: 10.21101/cejph.a6908. Cent Eur J Public Health. 2021. PMID: 35026070 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24 results

Search Page

Filters